Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
CON Stock Forecast 2026-2027
$23.86
Current Price
$3.06B
Market Cap
Buy 7
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to CON Price Targets
+29.9%
To High Target of $31.00
+21.5%
To Median Target of $29.00
+4.8%
To Low Target of $25.00
CON Price Momentum
+4.0%
1 Week Change
+19.9%
1 Month Change
+3.4%
1 Year Change
+21.2%
Year-to-Date Change
-0.5%
From 52W High of $23.99
+28.7%
From 52W Low of $18.55
📊 TOP ANALYST CALLS
Did CON Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Concentra is one of their latest high-conviction picks.
Latest CON Stock Price Targets & Analyst Predictions
Based on our analysis of 9 Wall Street analysts, CON has a bullish consensus with a median price target of $29.00 (ranging from $25.00 to $31.00). The overall analyst rating is Strong Buy (9.4/10). Currently trading at $23.86, the median forecast implies a 21.5% upside. This outlook is supported by 7 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Ben Hendrix at RBC Capital, projecting a 29.9% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CON Analyst Ratings
7
Buy
0
Hold
0
Sell
CON Price Target Range
Low
$25.00
Average
$29.00
High
$31.00
Current: $23.86
Latest CON Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CON.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 2, 2026 | RBC Capital | Ben Hendrix | Outperform | Maintains | $31.00 |
| Sep 18, 2025 | JP Morgan | Benjamin Rossi | Overweight | Assumes | $31.00 |
| Mar 19, 2025 | JP Morgan | Lisa Gill | Overweight | Maintains | $30.00 |
| Mar 12, 2025 | Wells Fargo | Overweight | Maintains | $25.00 | |
| Jan 23, 2025 | RBC Capital | Ben Hendrix | Outperform | Reiterates | $30.00 |
| Jan 23, 2025 | B of A Securities | Joanna Gajuk | Buy | Maintains | $25.00 |
| Dec 16, 2024 | B of A Securities | Buy | Upgrade | $N/A | |
| Nov 4, 2024 | RBC Capital | Ben Hendrix | Outperform | Maintains | $30.00 |
| Oct 7, 2024 | B of A Securities | Joanna Gajuk | Neutral | Downgrade | $24.00 |
| Aug 20, 2024 | RBC Capital | Ben Hendrix | Outperform | Initiates | $33.00 |
| Aug 19, 2024 | Goldman Sachs | Jamie Perse | Buy | Initiates | $32.00 |
| Aug 19, 2024 | JP Morgan | Lisa Gill | Overweight | Initiates | $29.00 |
| Aug 19, 2024 | Truist Securities | David Macdonald | Buy | Initiates | $29.00 |
| Aug 19, 2024 | Deutsche Bank | Justin Bowers | Buy | Initiates | $29.00 |
| Aug 19, 2024 | Wells Fargo | Overweight | Initiates | $27.00 | |
| Aug 19, 2024 | Mizuho | Ann Hynes | Outperform | Initiates | $28.00 |
| Aug 19, 2024 | B of A Securities | Joanna Gajuk | Buy | Initiates | $30.50 |
Concentra Group Holdings Inc. (CON) Competitors
The following stocks are similar to Concentra based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Concentra Group Holdings Inc. (CON) Financial Data
Concentra Group Holdings Inc. has a market capitalization of $3.06B with a P/E ratio of 20.1x. The company generates $2.09B in trailing twelve-month revenue with a 7.3% profit margin.
Revenue growth is +17.0% quarter-over-quarter, while maintaining an operating margin of +16.9% and return on equity of +44.8%.
Valuation Metrics
Market Cap
$3.06B
Enterprise Value
$5.13B
P/E Ratio
20.1x
PEG Ratio
7.4x
Price/Sales
1.4x
Growth & Margins
Revenue Growth (YoY)
+17.0%
Gross Margin
+29.2%
Operating Margin
+16.9%
Net Margin
+7.3%
EPS Growth
+8.8%
Financial Health
Cash/Price Ratio
+1.6%
Current Ratio
1.2x
Debt/Equity
522.0x
ROE
+44.8%
ROA
+7.8%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Concentra Group Holdings Inc. (CON) Business Model
About Concentra Group Holdings Inc.
What They Do
Provides healthcare and occupational health services.
Business Model
Concentra Group Holdings generates revenue by offering a variety of medical services, including occupational medicine, urgent care, and physical therapy. It serves clients ranging from large corporations to small businesses and government entities, focusing on workforce health through preventive care and injury treatment.
Additional Information
As a subsidiary of Select Medical Holdings Corporation, Concentra operates an extensive network of medical centers and on-site clinics, playing a vital role in reducing workplace injuries and managing employee health. The company adapts to evolving healthcare demands, solidifying its role in the occupational health market.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
8,758
CEO
Mr. William Keith Newton
Country
United States
IPO Year
N/A
Website
www.concentra.comConcentra Group Holdings Inc. (CON) Latest News & Analysis
Latest News
Quick Summary
Concentra Group Holdings (NYSE: CON) reported preliminary unaudited Q4 and full-year 2025 results, surpassing guidance. It also released a preliminary business outlook for 2026.
Why It Matters
Concentra's better-than-expected financial results and positive 2026 outlook indicate strong growth potential, likely boosting investor confidence and stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Concentra Expands to Tucker, Georgia
16 days ago
Quick Summary
Concentra (NYSE: CON) has opened a new medical center in Tucker, Georgia, enhancing its presence in the DeKalb County market.
Why It Matters
Concentra's expansion into Georgia enhances its market presence, potentially increasing revenue and market share, which can positively affect stock performance and investor confidence.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Concentra has acquired Reliant Immediate Care's assets in California, rebranding locations in Los Angeles as Concentra Century Airport and Concentra Downtown LA.
Why It Matters
Concentra's acquisition expands its market presence in California, enhancing growth potential and revenue streams, which could positively impact its stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Concentra Group Holdings Parent, Inc. (CON) presented at the 44th Annual J.P. Morgan Healthcare Conference, highlighting its strategic initiatives and future outlook.
Why It Matters
Concentra Group's presentation at a major healthcare conference signals potential strategic insights, partnerships, or innovations that could influence its stock performance and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Concentra (NYSE: CON) has opened a new medical center in Hialeah, Florida, aiming to enhance service to local employers and expand its operational presence in the area.
Why It Matters
Concentra's expansion into Hialeah signals growth potential, likely increasing revenue and market share in occupational medicine, positively impacting investor sentiment and stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Concentra Expands to Corona, California
2 months ago
Quick Summary
Concentra (NYSE: CON) has opened a new medical center in Corona, California, aimed at expanding access to occupational health services.
Why It Matters
Concentra's new center in California signifies growth and expansion, potentially boosting revenue and market presence, which can positively influence stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About CON Stock
What is Concentra Group Holdings Inc.'s (CON) stock forecast for 2026?
Based on our analysis of 9 Wall Street analysts, Concentra Group Holdings Inc. (CON) has a median price target of $29.00. The highest price target is $31.00 and the lowest is $25.00.
Is CON stock a good investment in 2026?
According to current analyst ratings, CON has 7 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $23.86. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CON stock?
Wall Street analysts predict CON stock could reach $29.00 in the next 12 months. This represents a 21.5% increase from the current price of $23.86. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Concentra Group Holdings Inc.'s business model?
Concentra Group Holdings generates revenue by offering a variety of medical services, including occupational medicine, urgent care, and physical therapy. It serves clients ranging from large corporations to small businesses and government entities, focusing on workforce health through preventive care and injury treatment.
What is the highest forecasted price for CON Concentra Group Holdings Inc.?
The highest price target for CON is $31.00 from Ben Hendrix at RBC Capital, which represents a 29.9% increase from the current price of $23.86.
What is the lowest forecasted price for CON Concentra Group Holdings Inc.?
Price targets from Wall Street analysts for CON are not currently available. The stock is trading at $23.86.
What is the overall CON consensus from analysts for Concentra Group Holdings Inc.?
The overall analyst consensus for CON is bullish. Out of 9 Wall Street analysts, 7 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $29.00.
How accurate are CON stock price projections?
Stock price projections, including those for Concentra Group Holdings Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: February 11, 2026 5:19 AM UTC